Full Text View
Tabular View
No Study Results Posted
Related Studies
Randomized Study of Recombinant Human Growth Hormone in Patients on Chronic Hemodialysis or Peritoneal Dialysis
This study has been completed.
Study NCT00004429   Information provided by FDA Office of Orphan Products Development
First Received: October 18, 1999   Last Updated: October 1, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Kidney Failure, Chronic
Additional conditions recognized in this trial
Kidney Failure
More general conditions related to this trial
Kidney Diseases
Renal Insufficiency
Renal Insufficiency, Chronic
Urologic Diseases
Interventions listed in this trial
growth hormone
Additional drug interventions recognized in this trial
Hormones
More general drug interventions related to this trial
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
FDA Office of Orphan Products Development
Vanderbilt University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services